总时间（秒）：17.70
问答时间（秒）：17.58

```json
[
  {
    "variant_string_id": "LRRK2 N1863K",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper focuses on mutations in the LRRK2 gene, which when mutated, results in increased kinase activity and phosphorylation of downstream targets, contributing to the pathogenesis of Parkinson's disease.",
        "judgment": "Yes",
        "reasoning": "The paper explicitly states the disease mechanism and the role of LRRK2 kinase activity.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "An in vitro kinase assay was performed using recombinant LRRK2 protein containing the N1863K mutation. The assay measured the phosphorylation of a substrate.  The assay included a wild-type control and a known pathogenic variant as positive controls.",
        "judgment": "Yes",
        "reasoning": "The enzyme assay is designed to test if the mutation impacts kinase activity as part of the disease mechanism, and includes necessary controls. ",
        "next_step_or_outcome": "Proceed to Sub-step 3a"
      },
      {
        "step_name": "Sub-step 3a: Basic Controls and Replicates",
        "extracted_paper_info": "The kinase assay included a wild-type control and a known pathogenic variant as positive controls. Replicates were performed 'in triplicate'.",
        "judgment": "Yes",
        "reasoning": "Both wild-type/null and pathogenic controls were utilized, and the study explicitly stated 'in triplicate' repetitions.",
        "next_step_or_outcome": "Proceed to Sub-step 3c"
      },
      {
        "step_name": "Sub-step 3c: Variant Controls",
        "extracted_paper_info": "The study included wild type and pathogenic variants. The pathogenic variant, G2019S, is known to increase LRRK2 kinase activity",
        "judgment": "Yes",
        "reasoning": "The paper utilizes known pathogenic variants to correlate with the N1863K variant. ",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "The researchers reported a significant increase in phosphorylation of the substrate in the N1863K mutant compared to wild type and G2019S. OddsPath was not reported.",
        "judgment": "Yes",
        "reasoning": "The variant resulted in a statistically significant change compared to other conditions. Statistical analysis was performed.",
        "next_step_or_outcome": "Proceed to Sub-step 4b"
      },
      {
        "step_name": "Sub-step 4b: No OddsPath Calculation",
        "extracted_paper_info": "The paper did not provide OddsPath values, but did state that the N1863K mutation significantly increased phosphorylation of the substrate.",
        "judgment": "Yes",
        "reasoning": "The paper does not provide any OddsPath values.  ",
        "next_step_or_outcome": "Proceed to final assessment"
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_moderate"
    },
    "overall_conclusion": "The N1863K mutation significantly increased phosphorylation, indicative of increased kinase activity, compared to controls. Lack of an OddsPath value, but significant functional data suggests a moderate degree of pathogenicity."
  }
]
```